We are live on ! Find out more
CA

Clune & Associates Portfolio holdings

AUM $661M
1-Year Est. Return 21.51%
This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
+21.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$365M
AUM Growth
+$39.7M
Cap. Flow
+$21.9M
Cap. Flow %
6%
Top 10 Hldgs %
34.94%
Holding
157
New
16
Increased
93
Reduced
32
Closed
1

Top Buys

Rank Stock Value
1
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$1.4M
2
DFIV icon
Dimensional International Value ETF
DFIV
+$1.26M
3
SGOV icon
iShares 0-3 Month Treasury Bond ETF
SGOV
+$1.17M
4
DFSD
Dimensional Short-Duration Fixed Income ETF
DFSD
+$1.1M
5
DFAS icon
Dimensional US Small Cap ETF
DFAS
+$1.03M

Top Sells

Rank Stock Value
1
MUB icon
iShares National Muni Bond ETF
MUB
+$1.22M
2
NVDA icon
NVIDIA
NVDA
+$517K
3
ABBV icon
AbbVie
ABBV
+$214K
4
MRK icon
Merck
MRK
+$200K
5
DUSB icon
Dimensional Ultrashort Fixed Income ETF
DUSB
+$185K

Sector Composition

Rank Sector Weight
1 Technology 3.82%
2 Financials 3.24%
3 Healthcare 1.48%
4 Industrials 1.26%
5 Consumer Discretionary 1.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITW icon
151
Illinois Tool Works
ITW
$81.4B
$204K 0.06%
827
– –
VEA icon
152
Vanguard FTSE Developed Markets ETF
VEA
$226B
$202K 0.06%
+3,548
New +$190K
ESGV icon
153
Vanguard ESG US Stock ETF
ESGV
$12.9B
$202K 0.06%
+1,841
New +$186K
EMXC icon
154
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.4B
$201K 0.06%
+3,188
New +$186K
PM icon
155
Philip Morris
PM
$301B
$200K 0.05%
+1,099
New +$189K
ABOS icon
156
Acumen Pharmaceuticals
ABOS
$154M
$19.1K 0.01%
16,500
– –
MRK icon
157
Merck
MRK
$324B
– –
-2,230
Closed -$200K
3 4 5 6
7

Similar funds

DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
FAM
Fulcrum Asset Management London, United Kingdom $662M AUM 48.09% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
HIG
Heritage Investment Group Pompano Beach, Florida $661M AUM 14.84% 1-Year Est. Return
RCG
Regatta Capital Group El Segundo, California $661M AUM 17.85% 1-Year Est. Return
AWA
Artemis Wealth Advisors New York $662M AUM 39.67% 1-Year Est. Return
FM
Freemont Management Vaud, Switzerland $661M AUM 60.48% 1-Year Est. Return
ACM
Arosa Capital Management Miami Beach, Florida $660M AUM 210.26% 1-Year Est. Return

Clune & Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Clune & Associates held 157 positions worth $365M, up 12% from $326M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Clune & Associates deployed $21.9M of net new capital in Q2 2025, opening 16 new positions and adding to 93 existing holdings. Its largest new stake was Invesco International Corporate Bond ETF: 24,469 shares worth $592K.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $1.22M trimmed.

  • Clune & Associates's largest Q2 2025 buy was Invesco International Corporate Bond ETF: 24,469 shares worth $592K.
  • Clune & Associates added most to Vanguard Short-Term Bond ETF in Q2 2025, an estimated $1.4M increase.
  • Clune & Associates's biggest Q2 2025 reduction was iShares National Muni Bond ETF, cutting an estimated $1.22M.
  • Clune & Associates fully exited Merck in Q2 2025, selling an estimated $200K.
  • Clune & Associates's ten largest holdings make up 35% of its $365M portfolio in Q2 2025.
  • Clune & Associates opened 16 new positions and closed 1 in Q2 2025.
  • Clune & Associates's portfolio value rose 12% quarter-over-quarter to $365M.

Based on Clune & Associates's 13F filing for Q2 2025, filed 30 Jul 2025.